KBÄ°721 - BASIC IMMUNOLOGY I
Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
---|---|---|---|---|---|---|
BASIC IMMUNOLOGY I | KBÄ°721 | 1st Semester | 3 | 0 | 3 | 8 |
Prequisites | None | |||||
Course language | Turkish | |||||
Course type | Elective | |||||
Mode of Delivery | Face-to-Face | |||||
Learning and teaching strategies | Lecture Discussion Question and Answer Preparing and/or Presenting Reports | |||||
Instructor (s) | Prof. Dr. Güneş Esendağlı, Doç. Dr. Hande Canpınar, Doç.Dr. Gürcan Günaydın, Doç.Dr. Neşe Ünver, Doç.Dr. Begüm Kocatürk | |||||
Course objective | To learn the principal properties and mechanisms of the immune system as well as its components. Each student is responsible for reading the suggested references for each lecture and preparing a seminar presentation. | |||||
Learning outcomes |
| |||||
Course Content | Tissues and cells of immune system, naive immunity, T cell ontogenesis and activation, B cell ontogenesis and activation, antigen, antigen processing and presentation, histocompatibility antigens, activation and regulation of complement system, functional and structural properties of immunoglobulins. | |||||
References | 1. Basic Immunology: Functions and Disorders of the Immune System, Abul K. Abbas, Andrew H., Md. Lichtman 2. Cellular and Molecular Immunology, Abul K. Abbas, Andrew H. Lichtman, Jordan S. Pober 3. Immunobiology, Charles Janeway, Mark Walport, Paul Travers 4. Immunology, Ivan M. Roitt, Jonathan Brostoff, David K. Male Medical Immunology, Tristram G. Parslow, Daniel P. Stites, Abba I. Terr, John B. Imboden 6. Molecular Biology of the Cell, Bruce Alberts, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, Peter Walter 7. Nature Reviews Immunology and Nature Reviews Cancer series |
Course outline weekly
Weeks | Topics |
---|---|
Week 1 | Properties of Immune System |
Week 2 | Tissues and Cells of Immune System |
Week 3 | Innate immunity |
Week 4 | Innate Lymphoid Cells |
Week 5 | Histocompatibility Antigens |
Week 6 | Antigen Presentation |
Week 7 | T Cell Ontogenesis and Activation |
Week 8 | Subsets of T Cells |
Week 9 | B cell ontogenesis and activation |
Week 10 | Antibodies and Antibody Dependent Immune Responses |
Week 11 | Immune Memory |
Week 12 | Termination of the Immune Response |
Week 13 | Antigens and Inflammatory responses |
Week 14 | Immune Metabolism |
Week 15 | General Exam Preparation |
Week 16 | Final Exam |
Assesment methods
Course activities | Number | Percentage |
---|---|---|
Attendance | 14 | 10 |
Laboratory | 0 | 0 |
Application | 0 | 0 |
Field activities | 0 | 0 |
Specific practical training | 0 | 0 |
Assignments | 0 | 0 |
Presentation | 1 | 20 |
Project | 0 | 0 |
Seminar | 0 | 0 |
Midterms | 0 | 0 |
Final exam | 1 | 70 |
Total | 100 | |
Percentage of semester activities contributing grade succes | 15 | 30 |
Percentage of final exam contributing grade succes | 1 | 70 |
Total | 100 |
WORKLOAD AND ECTS CALCULATION
Activities | Number | Duration (hour) | Total Work Load |
---|---|---|---|
Course Duration (x14) | 14 | 3 | 42 |
Laboratory | 0 | 0 | 0 |
Application | 0 | 0 | 0 |
Specific practical training | 0 | 0 | 0 |
Field activities | 0 | 0 | 0 |
Study Hours Out of Class (Preliminary work, reinforcement, ect) | 12 | 12 | 144 |
Presentation / Seminar Preparation | 1 | 24 | 24 |
Project | 0 | 0 | 0 |
Homework assignment | 0 | 0 | 0 |
Midterms (Study duration) | 0 | 0 | 0 |
Final Exam (Study duration) | 1 | 30 | 30 |
Total Workload | 28 | 69 | 240 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
D.9. Key Learning Outcomes | Contrubition level* | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
1. Can follow current, evidence-based and innovations in the field of vaccine technology at the doctoral level and can develop new thoughts and methods in the field by using high-level mental processes | X | ||||
2. Can plan an independent and original experimental study in the field of vaccine technology, make experimental design, perform experimental studies in appropriate environments, and analyze the data obtained and present the study outputs | X | ||||
3. Learns, uses and develops interdisciplinary interactions related to the field of Vaccine Technology | X | ||||
4. Knows the development steps of new carrier systems and adjuvants used in vaccine technology, learns the purpose of use of new technology systems by interpreting the advantages and deficiencies of the systems relative to each other | X | ||||
5. Can plan a scientific study using research techniques and statistical methods, and interact functionally by using strategic decision-making processes in solving the problems they will encounter | X | ||||
6. Knows the requirements of preclinical and clinical studies from vaccine production to commercialization, good laboratory practices (GLP) and good manufacturing practices (GMP) principles in vaccine production. In addition, they will have information about the legal regulations related to vaccine production and commercialization | X | ||||
7. Gains advanced knowledge about devices and tools used in vaccine technology | X | ||||
8. Can prepare an original scientific publication from these outputs by analyzing the findings obtained at the end of the studies carried out in the laboratory | X | ||||
9. Knows the place of vaccine technology in the international platform, follows up-to-date information in this field and catches scientific developments | X | ||||
10. Reaches scientific knowledge with a systematic approach in the field of vaccine technology, synthesizes it with a critical perspective, and can discuss and defend the information obtained with experts and uses this information for the benefit of society | X | ||||
11. Conducts scientific research and writes articles on vaccine technologies. Knows scientific project preparation processes and requirements | X |
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest